Loading...
6 Metabolic Disorder Drugs Reports
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Sanofi S.A., Perrigo Company plc, CSL Limited (Vifor Pharma Management Ltd.), AstraZeneca, Ardelyx
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific
Major Players: BioMarin Pharmaceuticals, SOM Innovation Biotech SL , Homology Medicines Inc. , Censa Pharmaceuticals (PTC Therapeutics), Codexis Inc.
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Heron Therapeutics, Inc., Helsinn Healthcare SA, Teva Pharmaceutical Industries Ltd., Novartis AG, Eisai Co., Ltd.
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Sanofi, Astellas Pharma Inc, Ardelyx, Alebund Pharmaceuticals, Kyowa Kirin Co., Ltd.
Study Period: 2021 - 2029
Regions Covered: North America, Europe, Asia Pacific
Major Players: Pfizer Inc, Takeda Pharmaceutical Company Limited (Shire Plc), Sanofi (Genzyme Corporation), BioMarin, Johnson & Johnson (Actelion Pharmaceuticals Ltd)
Study Period: 2019 - 2029
Country Covered: United States
Major Players: Merck & Co., Inc., AstraZeneca, Pfizer Inc., Novo Nordisk A/S, Sanofi
Filter Reports
By Region
By Countries
